A method for estimating pharmacokinetic risks of concentration-dependent drug interactions from preclinical data
2. M. Ramanathan. A method for estimating pharmacokinetic risks of concentration-dependent drug interactions from preclinical data. Drug Metab. Dispos. 27:1479-1487 (1999).
Therapeutic drug monitoring of antidepressants: Cost implications and relevance to clinical practice
4. M. J. Burke and S. H. Preskom. Therapeutic drug monitoring of antidepressants: cost implications and relevance to clinical practice. Clin. Pharmacokinet. 37:147-65 (1999).
Optimal sampling times for Bayesian estimation of the pharmacokinetic parameters of nortriptyline during therapeutic drug monitoring
5. Y. Merle and F. Mentre. Optimal sampling times for Bayesian estimation of the pharmacokinetic parameters of nortriptyline during therapeutic drug monitoring. J. Pharmacokinet. Biopharm. 27:85-101 (1999).
Population pharmacokinetic/pharmacodynamic methodology and applications: A bibliography
6. L. Yuh, S. Beal, M. Davidian, F. Harrison, A. Hester, K. Kowalski, E. Vonesh, and R. Wolfinger. Population pharmacokinetic/pharmacodynamic methodology and applications: a bibliography. Biometrics. 50:566-75 (1994).